BluePath Capital Management’s Medtronic MDT Stock Holding History

BluePath Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,957	Closed	-$805K	–	88
2025 Q1	$805K	Sell	8,957 -3,154	-26%	-$282K	0.84%	32
2024 Q4	$991K	Buy	12,111 +2,430	+25%	+$210K	0.53%	50
2024 Q3	$872K	Buy	9,681 +1,900	+24%	+$160K	0.54%	48
2024 Q2	$612K	Buy	7,781 +2,901	+59%	+$238K	0.43%	73
2024 Q1	$425K	Buy	4,880 +884	+22%	+$75.4K	0.32%	85
2023 Q4	$348K	Buy	3,996 +1,516	+61%	+$116K	0.3%	77
2023 Q3	$194K	Buy	+2,480	New	+$208K	0.18%	98

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BluePath Capital Management's MDT Position: Q2 2025 in Review

BluePath Capital Management sold out of Medtronic (MDT) in Q2 2025, closing a stake of 8,957 shares — an estimated $805K sold.

BluePath Capital Management first reported a position in MDT in Q3 2023 and held it in 7 quarters. The position peaked at $991K in Q4 2024. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

BluePath Capital Management reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
BluePath Capital Management sold 8,957 Medtronic shares in Q2 2025, an estimated $805K.
BluePath Capital Management first reported a position in Medtronic in Q3 2023 and held it in 7 quarters.
BluePath Capital Management's Medtronic position peaked at $991K in Q4 2024.
2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on BluePath Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.